ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,699.94
0.00%
Dow Jones
42,011.59
0.00%
US Dollar vs MXN
19.34135
-0.04%
Brent Oil
78.20
0.51%
Bitcoin
61,765.28
1.67%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
Símbolo:
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
04/10/202408:07Business WireA2 Bio to Present Safety and Biomarker Data from EVEREST-1 Trial during 2024 Annual Meeting of the Society for Immunotherapy of Cancer
04/10/202408:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AGRIAgriFORCE Growing Systems Ltd
04/10/202408:06Business WireODDSworks Launches iGaming With Novibet in Mexico
04/10/202408:06PR Newswire (Canada)Seuls des avertisseurs de fumée fonctionnels peuvent sauver des vies
04/10/202408:06PR Newswire (Canada)Only Working Smoke Alarms Can Save Lives
04/10/202408:05GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual MeetingNASDAQ:TCRXTScan Therapeutics Inc
04/10/202408:05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:KANTKineta Inc (PK)
04/10/202408:05GlobeNewswire Inc.Xilio Therapeutics Announces Upcoming Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual MeetingNASDAQ:XLOXilio Therapeutics Inc
04/10/202408:05GlobeNewswire Inc.NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual MeetingNASDAQ:NXTCNextCure Inc
04/10/202408:05GlobeNewswire Inc.Kineta Announces KVA12123 Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024NASDAQ:KAKineta Inc
04/10/202408:05PR Newswire (US)Carisma Therapeutics Announces Upcoming Presentations at SITC 2024NASDAQ:CARMCarisma Therapeutics Inc
04/10/202408:05GlobeNewswire Inc.Umoja Biopharma Announces Poster Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer
04/10/202408:05Business WireAulos Bioscience to Present Promising Phase 2 Data for Novel IL-2 Therapeutic Antibody, AU-007, at 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
04/10/202408:04PR Newswire (US)Sugar Grove Ace Celebrates 10th Anniversary with Community Event on October 12
04/10/202408:04GlobeNewswire Inc.BC NDP platform announces promising initiatives, but immediate action needed says United Steelworkers union
04/10/202408:03Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
04/10/202408:03GlobeNewswire Inc.DMG Blockchain Solutions Announces Preliminary September 2024 Operational ResultsTSXV:DMGIDMG Blockchain Solutions Inc
04/10/202408:02Business WirePeak Mobile Vascular Expands Services to the Midwest
04/10/202408:02Business WireBitwise Files To Convert Three Futures-Based ETFs to New “Trendwise” Strategies
04/10/202408:02PR Newswire (US)Schoox Honored in Training Industry's List of 'Top 20 LMS Companies' for a Third Consecutive Year
04/10/202408:01Business WireSkyWest, Inc. Announces Third Quarter 2024 Results Call DateNASDAQ:SKYWSkyWest Inc
04/10/202408:01PR Newswire (Canada)Métaux Russel conférence téléphonique - résultats du troisième trimestre 2024TSX:RUSRussel Metals Inc
04/10/202408:00GlobeNewswire Inc.Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual MeetingNASDAQ:CADLCandel Therapeutics Inc
04/10/202408:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEHLAntelope Enterprise Holdings Ltd
04/10/202408:00GlobeNewswire Inc.NEXGEL Appoints Kip Crecca to its Scientific Advisory BoardNASDAQ:NXGLNexGel Inc
04/10/202408:00GlobeNewswire Inc.STMicroelectronics Announces Timing for Third Quarter 2024 Earnings Release and Conference Call and Capital Markets Day WebcastEU:STMPAST Microelectronics
04/10/202408:00GlobeNewswire Inc.SB Financial Group, Inc. Announces Schedule for Third Quarter 2024 ResultsNASDAQ:SBFGSB Finanical Group Inc
04/10/202408:00Business WireGrammarly Named an Emerging Leader in Gartner® “Emerging Market Quadrant for Generative AI Technologies”
04/10/202408:00Business WireClasp Therapeutics to Present Preclinical Data Evaluating Novel T Cell Engager Targeting p53 Mutant Solid Tumors
04/10/202408:00GlobeNewswire Inc.Immatics Announces Upcoming Oral and Poster Presentations at the Society for Immunotherapy of Cancer Annual Meeting 2024NASDAQ:IMTXImmatics NV

Su Consulta Reciente

CCOM
OILBRENT
Brent Oil
NYSE
BAC
Bank of America
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLV
Health Care Select Sector
COIN
SOLUSD
Solana
COIN
AVAXUSD
Avalanche
COIN
ETHUSD
Ethereum
NASDAQ
TSLA
Tesla
NYSE
NKE
Nike
NYSE
DIS
Walt Disney
COIN
XRPUSD
Ripple
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
ADAUSD
Cardano
USOTC
ADDYY
Adidas (QX)
NYSE
CVX
Chevron
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados